NBCRNA NATIONAL CERTIFICATION EXAMINATION
(NCE) COMPLETE PRACTICE EXAM | 2026/2027
EDITION | 200 VERIFIED QUESTIONS
NBCRNA NCE 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest Guidelines | Graded A+
This comprehensive practice exam is meticulously designed to prepare candidates for the National
Board of Certification and Recertification for Nurse Anesthetists (NBCRNA) National Certification
Examination (NCE). Featuring 200 verified questions with detailed rationales, this resource reflects the
latest exam blueprint and clinical guidelines. Each question is crafted to mirror the format and
difficulty of the actual NCE, ensuring thorough readiness. Ideal for both initial certification and
recertification candidates, this document provides a robust self-assessment tool to identify strengths
and areas for improvement.
Key Features:
200 verified multiple-choice questions with correct answers and detailed rationales
Covers all core content areas: Basic Sciences, Equipment & Technology, Pharmacology, and Clinical Principles
Updated to reflect 2026/2027 NBCRNA exam blueprint and current anesthesia practice standards
Includes distractors with explanations to enhance critical thinking and test-taking skills
Organized by content area with question ranges and weight percentages for targeted study
Updates for 2026:
- Integrated latest AANA Practice Guidelines and safety standards
- Revised pharmacology questions to include new anesthetic agents and reversal drugs
- Updated equipment and technology section to reflect advances in monitoring and delivery systems
- Enhanced rationales with evidence-based references and clinical correlations
- Aligned question weighting with current NBCRNA exam specifications
Abstract:
This practice examination is a comprehensive study aid for the NBCRNA National Certification Examination
(NCE), containing 200 verified questions with detailed rationales. The content is organized into four major
domains: Basic Sciences (including anatomy, physiology, and pathophysiology), Equipment and Technology
(anesthesia machines, monitoring devices, and safety systems), Pharmacology (pharmacokinetics,
pharmacodynamics, and anesthetic agents), and Clinical Principles (preoperative assessment, intraoperative
management, and postoperative care). Each question is accompanied by a correct answer, a thorough rationale
explaining the underlying concepts, and analysis of incorrect distractors to reinforce learning. The exam blueprint
follows the 2026/2027 NBCRNA guidelines, ensuring relevance and accuracy. This resource is designed to
simulate the actual test environment, helping candidates build confidence and identify knowledge gaps. Rationales
are written in a clear, academic style, citing current literature and clinical best practices. The document also
includes a compliance checklist and content area breakdowns to facilitate structured study plans.
Keywords:
NBCRNA NCE, CRNA certification exam, nurse anesthesia practice exam, 200 questions with rationales,
anesthesia board review, 2026/2027 exam prep, certification test bank, anesthesia pharmacology
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale explaining why it is correct and why the other options are incorrect. Distractor
analyses are provided to clarify common misconceptions and reinforce key concepts.
Page 1
,Compliance Checklist:
All questions verified against current NBCRNA exam blueprint
Rationales cite evidence-based sources and clinical guidelines
Content reflects 2026/2027 practice standards and safety protocols
Questions are formatted to match actual NCE style and difficulty
Answer key includes correct answer, rationale, and distractor explanations
Weighted content areas align with official exam specifications
Content Area Overview:
Content Area Questions Key Topics Weight
Basic Sciences 1-50 Anatomy, Physiology, Pathophysiology, 25%
Chemistry, Physics
Equipment and Technology 51-90 Anesthesia Machine, Monitoring Devices, 20%
Airway Equipment, Safety Systems
Pharmacology 91-140 Pharmacokinetics, Pharmacodynamics, 25%
Anesthetic Agents, Adjuncts, Reversal
Drugs
Clinical Principles 141-200 Preoperative Assessment, Intraoperative 30%
Management, Postoperative Care, Special
Populations
Page 2
,Q1. A patient with a history of chronic opioid use presents for elective surgery. The anesthesia
provider plans to use remifentanil as part of a balanced technique. Which pharmacologic property
of remifentanil most significantly influences the risk of acute opioid tolerance and postoperative
hyperalgesia in this population?
A. Context-sensitive half-time independent of infusion duration
B. Rapid hydrolysis by nonspecific plasma esterases
C. High mu-opioid receptor binding affinity with rapid dissociation
D. Absence of active metabolites
Correct Answer: A. Context-sensitive half-time independent of infusion duration
Rationale: Remifentanil's context-sensitive half-time remains constant regardless of infusion duration due
to its ester hydrolysis metabolism. This property allows rapid offset, which can lead to acute opioid
tolerance and hyperalgesia, especially in opioid-tolerant patients. Options B and D are true but do not
directly explain tolerance/hyperalgesia risk. Option C is incorrect because remifentanil has moderate
binding affinity, not high.
Why Wrong:
B - Rapid hydrolysis explains quick offset but not the development of tolerance.
C - Remifentanil has moderate, not high, mu-receptor binding affinity.
D - Lack of active metabolites is a safety feature but unrelated to tolerance.
Reference: Egan, T.D. (2020). Remifentanil: A unique opioid. In Anesthesia Pharmacology, 3rd Ed., Ch.
12.
Q2. During a laparoscopic cholecystectomy, the anesthesia provider notes a sudden increase in
end-tidal carbon dioxide (ETCO2) from 35 to 55 mmHg over 5 minutes, accompanied by a decrease
in oxygen saturation to 88% and hypotension. Which of the following is the most likely cause?
A. Venous air embolism
B. Carbon dioxide embolism
C. Bronchospasm
D. Pneumothorax
Correct Answer: B. Carbon dioxide embolism
Rationale: Sudden rise in ETCO2, hypoxemia, and hypotension during laparoscopic surgery with CO2
insufflation is classic for CO2 embolism. CO2 is highly soluble, so ETCO2 rises initially, but later may
fall with massive embolus. Venous air embolism (A) typically causes a decrease in ETCO2. Bronchospasm
(C) would increase airway pressures and ETCO2 may not rise as abruptly. Pneumothorax (D) may cause
hypotension and hypoxemia but not a sudden rise in ETCO2.
Why Wrong:
A - Venous air embolism typically causes a decrease, not increase, in ETCO2.
C - Bronchospasm is associated with wheezing and increased airway pressure, not abrupt ETCO2
rise.
D - Pneumothorax leads to decreased breath sounds and hypotension, but ETCO2 may not rise
suddenly.
Reference: Miller, R.D. (2020). Miller's Anesthesia, 9th Ed., Ch. 44 (Laparoscopic Surgery).
Page 3
, Q3. A patient with a history of malignant hyperthermia (MH) requires emergency surgery. The
anesthesia provider prepares a total intravenous anesthesia (TIVA) technique. Which of the
following drug combinations is safest for this patient?
A. Propofol, fentanyl, rocuronium, and sevoflurane
B. Ketamine, propofol, remifentanil, and cisatracurium
C. Etomidate, sufentanil, succinylcholine, and desflurane
D. Propofol, fentanyl, succinylcholine, and isoflurane
Correct Answer: B. Ketamine, propofol, remifentanil, and cisatracurium
Rationale: MH-triggering agents are volatile anesthetics and succinylcholine. Option B uses only
non-triggering agents: ketamine, propofol, remifentanil, and cisatracurium (a nondepolarizing muscle
relaxant). Options A, C, and D include volatile anesthetics or succinylcholine, which are contraindicated
in MH-susceptible patients.
Why Wrong:
A - Sevoflurane is a volatile anesthetic that triggers MH.
C - Succinylcholine and desflurane are both MH triggers.
D - Succinylcholine and isoflurane are MH triggers.
Reference: Rosenberg, H. et al. (2020). Malignant Hyperthermia. In Anesthesiology, 132(5), 1034-1048.
Q4. A patient undergoing a craniotomy for tumor resection has a mean arterial pressure (MAP) of
55 mmHg at baseline. The surgeon requests moderate hypotension to reduce bleeding. Which of the
following agents is most appropriate to maintain cerebral perfusion pressure (CPP) while achieving
controlled hypotension?
A. Sodium nitroprusside
B. Nicardipine
C. Esmolol
D. Labetalol
Correct Answer: B. Nicardipine
Rationale: Nicardipine is a dihydropyridine calcium channel blocker that causes arterial vasodilation
with minimal venodilation, preserving cardiac output and CPP. Sodium nitroprusside (A) can increase
intracranial pressure (ICP) and cause cyanide toxicity. Esmolol (C) and labetalol (D) are beta-blockers
that decrease heart rate and contractility, potentially reducing CPP further in a hypotensive patient.
Why Wrong:
A - Sodium nitroprusside can increase ICP and has risk of cyanide toxicity.
C - Esmolol reduces heart rate and contractility, which may lower CPP.
D - Labetalol has beta-blocking effects that can reduce cardiac output and CPP.
Reference: Patel, P.M. & Drummond, J.C. (2020). Anesthesia for Neurosurgery. In Miller's Anesthesia,
9th Ed., Ch. 49.
Page 4
(NCE) COMPLETE PRACTICE EXAM | 2026/2027
EDITION | 200 VERIFIED QUESTIONS
NBCRNA NCE 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions |
Updated Per Latest Guidelines | Graded A+
This comprehensive practice exam is meticulously designed to prepare candidates for the National
Board of Certification and Recertification for Nurse Anesthetists (NBCRNA) National Certification
Examination (NCE). Featuring 200 verified questions with detailed rationales, this resource reflects the
latest exam blueprint and clinical guidelines. Each question is crafted to mirror the format and
difficulty of the actual NCE, ensuring thorough readiness. Ideal for both initial certification and
recertification candidates, this document provides a robust self-assessment tool to identify strengths
and areas for improvement.
Key Features:
200 verified multiple-choice questions with correct answers and detailed rationales
Covers all core content areas: Basic Sciences, Equipment & Technology, Pharmacology, and Clinical Principles
Updated to reflect 2026/2027 NBCRNA exam blueprint and current anesthesia practice standards
Includes distractors with explanations to enhance critical thinking and test-taking skills
Organized by content area with question ranges and weight percentages for targeted study
Updates for 2026:
- Integrated latest AANA Practice Guidelines and safety standards
- Revised pharmacology questions to include new anesthetic agents and reversal drugs
- Updated equipment and technology section to reflect advances in monitoring and delivery systems
- Enhanced rationales with evidence-based references and clinical correlations
- Aligned question weighting with current NBCRNA exam specifications
Abstract:
This practice examination is a comprehensive study aid for the NBCRNA National Certification Examination
(NCE), containing 200 verified questions with detailed rationales. The content is organized into four major
domains: Basic Sciences (including anatomy, physiology, and pathophysiology), Equipment and Technology
(anesthesia machines, monitoring devices, and safety systems), Pharmacology (pharmacokinetics,
pharmacodynamics, and anesthetic agents), and Clinical Principles (preoperative assessment, intraoperative
management, and postoperative care). Each question is accompanied by a correct answer, a thorough rationale
explaining the underlying concepts, and analysis of incorrect distractors to reinforce learning. The exam blueprint
follows the 2026/2027 NBCRNA guidelines, ensuring relevance and accuracy. This resource is designed to
simulate the actual test environment, helping candidates build confidence and identify knowledge gaps. Rationales
are written in a clear, academic style, citing current literature and clinical best practices. The document also
includes a compliance checklist and content area breakdowns to facilitate structured study plans.
Keywords:
NBCRNA NCE, CRNA certification exam, nurse anesthesia practice exam, 200 questions with rationales,
anesthesia board review, 2026/2027 exam prep, certification test bank, anesthesia pharmacology
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale explaining why it is correct and why the other options are incorrect. Distractor
analyses are provided to clarify common misconceptions and reinforce key concepts.
Page 1
,Compliance Checklist:
All questions verified against current NBCRNA exam blueprint
Rationales cite evidence-based sources and clinical guidelines
Content reflects 2026/2027 practice standards and safety protocols
Questions are formatted to match actual NCE style and difficulty
Answer key includes correct answer, rationale, and distractor explanations
Weighted content areas align with official exam specifications
Content Area Overview:
Content Area Questions Key Topics Weight
Basic Sciences 1-50 Anatomy, Physiology, Pathophysiology, 25%
Chemistry, Physics
Equipment and Technology 51-90 Anesthesia Machine, Monitoring Devices, 20%
Airway Equipment, Safety Systems
Pharmacology 91-140 Pharmacokinetics, Pharmacodynamics, 25%
Anesthetic Agents, Adjuncts, Reversal
Drugs
Clinical Principles 141-200 Preoperative Assessment, Intraoperative 30%
Management, Postoperative Care, Special
Populations
Page 2
,Q1. A patient with a history of chronic opioid use presents for elective surgery. The anesthesia
provider plans to use remifentanil as part of a balanced technique. Which pharmacologic property
of remifentanil most significantly influences the risk of acute opioid tolerance and postoperative
hyperalgesia in this population?
A. Context-sensitive half-time independent of infusion duration
B. Rapid hydrolysis by nonspecific plasma esterases
C. High mu-opioid receptor binding affinity with rapid dissociation
D. Absence of active metabolites
Correct Answer: A. Context-sensitive half-time independent of infusion duration
Rationale: Remifentanil's context-sensitive half-time remains constant regardless of infusion duration due
to its ester hydrolysis metabolism. This property allows rapid offset, which can lead to acute opioid
tolerance and hyperalgesia, especially in opioid-tolerant patients. Options B and D are true but do not
directly explain tolerance/hyperalgesia risk. Option C is incorrect because remifentanil has moderate
binding affinity, not high.
Why Wrong:
B - Rapid hydrolysis explains quick offset but not the development of tolerance.
C - Remifentanil has moderate, not high, mu-receptor binding affinity.
D - Lack of active metabolites is a safety feature but unrelated to tolerance.
Reference: Egan, T.D. (2020). Remifentanil: A unique opioid. In Anesthesia Pharmacology, 3rd Ed., Ch.
12.
Q2. During a laparoscopic cholecystectomy, the anesthesia provider notes a sudden increase in
end-tidal carbon dioxide (ETCO2) from 35 to 55 mmHg over 5 minutes, accompanied by a decrease
in oxygen saturation to 88% and hypotension. Which of the following is the most likely cause?
A. Venous air embolism
B. Carbon dioxide embolism
C. Bronchospasm
D. Pneumothorax
Correct Answer: B. Carbon dioxide embolism
Rationale: Sudden rise in ETCO2, hypoxemia, and hypotension during laparoscopic surgery with CO2
insufflation is classic for CO2 embolism. CO2 is highly soluble, so ETCO2 rises initially, but later may
fall with massive embolus. Venous air embolism (A) typically causes a decrease in ETCO2. Bronchospasm
(C) would increase airway pressures and ETCO2 may not rise as abruptly. Pneumothorax (D) may cause
hypotension and hypoxemia but not a sudden rise in ETCO2.
Why Wrong:
A - Venous air embolism typically causes a decrease, not increase, in ETCO2.
C - Bronchospasm is associated with wheezing and increased airway pressure, not abrupt ETCO2
rise.
D - Pneumothorax leads to decreased breath sounds and hypotension, but ETCO2 may not rise
suddenly.
Reference: Miller, R.D. (2020). Miller's Anesthesia, 9th Ed., Ch. 44 (Laparoscopic Surgery).
Page 3
, Q3. A patient with a history of malignant hyperthermia (MH) requires emergency surgery. The
anesthesia provider prepares a total intravenous anesthesia (TIVA) technique. Which of the
following drug combinations is safest for this patient?
A. Propofol, fentanyl, rocuronium, and sevoflurane
B. Ketamine, propofol, remifentanil, and cisatracurium
C. Etomidate, sufentanil, succinylcholine, and desflurane
D. Propofol, fentanyl, succinylcholine, and isoflurane
Correct Answer: B. Ketamine, propofol, remifentanil, and cisatracurium
Rationale: MH-triggering agents are volatile anesthetics and succinylcholine. Option B uses only
non-triggering agents: ketamine, propofol, remifentanil, and cisatracurium (a nondepolarizing muscle
relaxant). Options A, C, and D include volatile anesthetics or succinylcholine, which are contraindicated
in MH-susceptible patients.
Why Wrong:
A - Sevoflurane is a volatile anesthetic that triggers MH.
C - Succinylcholine and desflurane are both MH triggers.
D - Succinylcholine and isoflurane are MH triggers.
Reference: Rosenberg, H. et al. (2020). Malignant Hyperthermia. In Anesthesiology, 132(5), 1034-1048.
Q4. A patient undergoing a craniotomy for tumor resection has a mean arterial pressure (MAP) of
55 mmHg at baseline. The surgeon requests moderate hypotension to reduce bleeding. Which of the
following agents is most appropriate to maintain cerebral perfusion pressure (CPP) while achieving
controlled hypotension?
A. Sodium nitroprusside
B. Nicardipine
C. Esmolol
D. Labetalol
Correct Answer: B. Nicardipine
Rationale: Nicardipine is a dihydropyridine calcium channel blocker that causes arterial vasodilation
with minimal venodilation, preserving cardiac output and CPP. Sodium nitroprusside (A) can increase
intracranial pressure (ICP) and cause cyanide toxicity. Esmolol (C) and labetalol (D) are beta-blockers
that decrease heart rate and contractility, potentially reducing CPP further in a hypotensive patient.
Why Wrong:
A - Sodium nitroprusside can increase ICP and has risk of cyanide toxicity.
C - Esmolol reduces heart rate and contractility, which may lower CPP.
D - Labetalol has beta-blocking effects that can reduce cardiac output and CPP.
Reference: Patel, P.M. & Drummond, J.C. (2020). Anesthesia for Neurosurgery. In Miller's Anesthesia,
9th Ed., Ch. 49.
Page 4
